Leo Ehrlich

Chief Executive Officer chez INNOVATION PHARMACEUTICALS INC. Fortune : 99 207 $ au 31/03/2024

Profil

Leo Ehrlich is the founder of Innovation Pharmaceuticals, Inc., which was founded in 2007.
He currently holds the titles of Chairman, CEO, Chief Financial Officer, and Secretary at the company.
Mr. Ehrlich also has former job experience, including being the Chief Financial Officer and Director at NanoViricides, Inc. He was also the President, COO, CFO, and Secretary at StatSure Diagnostic Systems, Inc. for a brief period in 2010.
From 2005 to 2007, Mr. Ehrlich served as the Chief Financial Officer at NanoViricides, Inc. He also briefly held the position of Chief Financial Officer at Cellceutix Pharma, Inc. in 2007.
Mr. Ehrlich's education includes an undergraduate degree from Baruch College.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
INNOVATION PHARMACEUTICALS INC. 27,71%	28/09/2023	4 333 936 ( 27,71% )	60 675 $	31/03/2024
INNOVATION PHARMACEUTICALS INC. 0,54%	28/09/2023	2 752 310 ( 0,54% )	38 532 $	31/03/2024

Postes actifs de Leo Ehrlich

Sociétés	Poste	Début
INNOVATION PHARMACEUTICALS INC.	Chief Executive Officer	05/11/2010

Anciens postes connus de Leo Ehrlich

Sociétés	Poste	Fin
Cellceutix Pharma, Inc.	Director of Finance/CFO	06/12/2007
NANOVIRICIDES, INC.	Director of Finance/CFO	16/05/2007
NanoViricides, Inc. /Old/	Director of Finance/CFO	01/05/2007
STATSURE DIAGNOSTIC SYSTEMS, INC.	Chief Executive Officer	-

Formation de Leo Ehrlich

Baruch College

Undergraduate Degree